Indago Research and Health Center, Inc.

Hialeah, Florida 33012

0 studies enrolling now · 10 studies all time

What they study most

Alzheimer Disease, COVID-19, Diabetes Mellitus, Type 2, Non-Alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, Nonalcoholic Steatohepatitis, Osteoporosis, Postmenopausal, Pneumococcal Disease, SARS-CoV-2 Infection, COVID-19, Sars-CoV-2 Infection, Type 2 Diabetes Mellitus

Studies at this site

• Efficacy and Safety of NVX-CoV2705 — Running, not enrolling
• Study of Semaglutide, and Cilofexor/Firsocostat, Alone and in Combination, in Adults With Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) — Completed
• Simufilam 50 mg or 100 mg for Mild-to-Moderate Alzheimer's Disease — Stopped early
• Comparative Efficacy, Safety, PK, and Immunogenicity Study — Status unconfirmed
• Vitamin E and DHA-EE on NAFLD - Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Trial (PUVENAFLD) — Completed
• GAIN Trial: Phase 2/3 Study of COR388 in Subjects With Alzheimer's Disease — Completed
• Safety and Immunogenicity of 20vPnC Coadministered With SIIV in Adults ≥65 Years of Age — Completed
• Safety, Tolerability and Efficacy of Molnupiravir (EIDD-2801) to Eliminate Infectious Virus Detection in Persons With COVID-19 — Completed
• Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on Metformin — Stopped early
• Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM — Completed